Amabiotics is a biopharmaceutical company that develops innovative microbiome-derived medicines to fight age-related diseases. Our research focuses on Gut-Brain axis. AMABIOTICS’ lead candidate is AMA-101, a potential first-in-class therapy for Parkinson’s disease. We aim to satisfy unmet medical needs using microbiome-derived medicines and become the leading provider of therapeutics based on the human microbiome. Due to millions of years of coevolution, complex metabolic interactions exist between humans and their gut microbiota. Amabiotics uncovered a unique set of metabolites produced by healthy gut microbiota and involved in the maintenance of health.
View Top Employees from Amabiotics| Website | http://www.amabiotics.com/ |
| Employees | 10 (10 on RocketReach) |
| Founded | 2010 |
Looking for a particular Amabiotics employee's phone or email?
Amabiotics Questions
David Immke is the Chief Scientific Officer of Amabiotics.
10 people are employed at Amabiotics.
Amabiotics is based in Paris, Île-De-France.
Top Amabiotics Employees
-
25+
-
11
-
ViewJonathan Weiss
Director of Business Development at Amabiotics
New York, New York, United States22 -
1
